Rare
lephants
Screener
Toggle theme
Organogenesis Holdings Inc.
ORGO
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2024
FY2023
FY2022
FY2021
FY2020
Total Cash from Operations:
$52.7M
Line Item
Value
% of Total
Capital Expenditures
$10.0M
19.0%
Working Capital
$10.9M
20.6%
Net Cash Flow
$31.8M
60.4%
Download CSV
